MedTrace Logo

Ketamine in Refractory Convulsive Status Epilepticus

NCT02431663 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2020-10-08

No results posted yet for this study

Summary

To evaluate the efficacy of intravenous administration of ketamine in the treatment of refractory convulsive status epilepticus in children compared to administration of midazolam at high doses, thiopental and / or propofol.

Conditions

  • Status Epilepticus

Interventions

DRUG

Ketamine

Intravenous administration in continuous

Sponsors & Collaborators

  • Ospedali Riuniti Ancona

    collaborator OTHER

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    collaborator OTHER

  • University of Padova

    collaborator OTHER

  • Bambino Gesù Hospital and Research Institute

    collaborator OTHER

  • Catholic University of the Sacred Heart

    collaborator OTHER

  • IRCCS Burlo Garofolo

    collaborator OTHER

  • Azienda Ospedaliera Universitaria Integrata Verona

    collaborator OTHER

  • Nuovo Regina Margherita Hospital

    collaborator OTHER

  • Vittore Buzzi Children's Hospital

    collaborator OTHER

  • Meyer Children's Hospital IRCCS

    lead OTHER

Principal Investigators

  • Anna Rosati, MD, PhD · Children's Hospital A. Meyer of Firenze, Italy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02431663 on ClinicalTrials.gov